158.274 de modificări
Moderna Inc.: Diferență între versiuni
fără descrierea modificării
Admin (discuție | contribuții) (csv2wiki) |
Admin (discuție | contribuții) Fără descriere a modificării |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei Moderna Inc. listata cu simbolul US.MRNA | Pagina dedicata companiei Moderna Inc. listata cu simbolul US.MRNA | ||
==Descriere companie== | ==Descriere companie== | ||
Moderna, Inc. (https://www.modernatx.com/) is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics. | Moderna, Inc. (https://www.modernatx.com/) is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics. | ||
==Grafic actiuni companie== | |||
<iframe key="tradeville" path="graficSimbol/US.MRNA" /> | |||
==Ultimele stiri despre Moderna Inc. (US.MRNA)== | ==Ultimele stiri despre Moderna Inc. (US.MRNA)== | ||
| Linia 15: | Linia 14: | ||
addfirstcategorydate=false | addfirstcategorydate=false | ||
</dynamicpagelist> | </dynamicpagelist> | ||
[[Categorie:US.MRNA]][[Categorie:Stiri despre companii]] | [[Categorie:US.MRNA]][[Categorie:Stiri despre companii]] | ||